World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
73
Citations
24967
World Ranking
2103
National Ranking
21

Overview

Javier Martinez-Picado is affiliated with the University of Vic - Central University of Catalonia in Spain. Their research spans multiple areas within medicine, with a primary focus on infectious diseases and immunology. The scientist's work prominently addresses HIV research alongside investigations into SARS-CoV-2 and COVID-19.

The main fields of study for Javier Martinez-Picado include Medicine and Immunology and Microbiology. Subfields of expertise are Infectious Diseases, Virology, Immunology, Epidemiology, and Molecular Biology. Topics frequently covered in their research include:

  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • Immune Cell Function and Interaction
  • SARS-CoV-2 and COVID-19 Research
  • Cytomegalovirus and herpesvirus research
  • Immunotherapy and Immune Responses

The scientist has contributed articles to several notable publication venues, including:

  • Nature Medicine
  • Frontiers in Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature
  • Nature Communications

Recent papers authored or co-authored by Javier Martinez-Picado include:

  • "Autoantibodies against type I IFNs in patients with life-threatening COVID-19," 2020, Science
  • "Human genetic and immunological determinants of critical COVID-19 pneumonia," 2022, Nature
  • "Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies," 2021, Nature
  • "Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report," 2020, The Lancet HIV
  • "In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation," 2023, Nature Medicine

Javier Martinez-Picado often collaborates with a consistent group of co-authors, including:

  • María C. Puertas
  • Bonaventura Clotet
  • Beatriz Mothe
  • María Salgado
  • Víctor Urrea

Best Publications

  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

    Paul Bastard;Paul Bastard;Paul Bastard;Lindsey B. Rosen;Qian Zhang;Eleftherios Michailidis

  • A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1

    Jacques Fellay;Kevin V. Shianna;Dongliang Ge;Sara Colombo

  • HIV evolution: CTL escape mutation and reversion after transmission.

    A J Leslie;K J Pfafferott;P Chetty;R Draenert

  • HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation

    Ravindra K. Gupta;Sultan Abdul-Jawad;Laura E. McCoy;Hoi Ping Mok

  • HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects

    Maria J Buzón;Marta Massanella;Josep M Llibre;Anna Esteve

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Towards an HIV cure: a global scientific strategy

    Steven G Deeks;Brigitte Autran;Ben Berkhout;Monsef Benkirane

  • Human genetic and immunological determinants of critical COVID-19 pneumonia

    Unknown

  • Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1

    Javier Martinez-Picado;Julia G. Prado;Elizabeth E. Fry;Katja Pfafferott

  • Replicative Fitness of Protease Inhibitor-Resistant Mutants of Human Immunodeficiency Virus Type 1

    Javier Martinez-Picado;Anu V. Savara;Lorraine Sutton;Richard T. D’Aquila

  • Common genetic variation and the control of HIV-1 in humans.

    Jacques Fellay;Dongliang Ge;Kevin V. Shianna;Sara Colombo

  • Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection.

    Rika Draenert;Sylvie Le Gall;Katja J. Pfafferott;Alasdair J. Leslie

  • Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

    Christine Katlama;Steven G Deeks;Brigitte Autran;Javier Martinez-Picado

  • Long-Term Antiretroviral Treatment Initiated at Primary HIV-1 Infection Affects the Size, Composition, and Decay Kinetics of the Reservoir of HIV-1-Infected CD4 T Cells

    Maria J. Buzon;Enrique Martin-Gayo;Florencia Pereyra;Zhengyu Ouyang

  • Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies.

    Florian A. Lempp;Leah B. Soriaga;Martin Montiel-Ruiz;Fabio Benigni

  • Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway

    Nuria Izquierdo-Useros;Mar Naranjo-Gómez;Jacob Archer;Steven C. Hatch

  • Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure

    Veronica Miller;Caroline Sabin;Kurt Hertogs;Stuart Bloor

  • Antiretroviral resistance during successful therapy of HIV type 1 infection

    J. Martinez-Picado;M. P. DePasquale;N. Kartsonis;G. J. Hanna

  • Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides.

    Nuria Izquierdo-Useros;Maier Lorizate;Maria C. Puertas;Maria T. Rodriguez-Plata

  • The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

    Unknown

  • Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression.

    Lidia Ruiz;Javier Martinez-Picado;Joan Romeu;Roger Paredes

  • Common Genetic Variation and the Control of HIV-1 in Humans

    Jacques Fellay;Dongliang Ge;Kevin V. Shianna;Sara Colombo

Frequent Co-Authors

Julià Blanco
Julià Blanco IrsiCaixa
Jacques Fellay
Jacques Fellay École Polytechnique Fédérale de Lausanne
Lidia Ruiz
Lidia Ruiz IrsiCaixa
Amalio Telenti
Amalio Telenti VIR Biotechnology (United States)
Bruce D. Walker
Bruce D. Walker Harvard University
Philip J. R. Goulder
Philip J. R. Goulder University of Oxford
Roger Paredes
Roger Paredes University of Vic - Central University of Catalonia
Eugenia Negredo
Eugenia Negredo University of Vic - Central University of Catalonia
Luis Menéndez-Arias
Luis Menéndez-Arias Spanish National Research Council

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring immunology in the USA opens doors to diverse healthcare careers, many of which benefit from specialized nursing education. For professionals looking to advance quickly, accelerated nurse practitioner programs offer a fast track to becoming a nurse practitioner, combining rigorous study with flexible online formats.

Those aiming to transition within nursing specialties might consider the fnp to acute care np bridge program, which facilitates moving from family nurse practitioner roles to acute care settings, aligning well with careers involving immunology in critical care environments.

For individuals without a nursing background but interested in joining this vital field, online rn programs for non nurses in florida provide accessible pathways into nursing. These programs help build foundational skills necessary for roles supporting immunology research and patient care.

Additionally, enrolling in accelerated nursing programs can be an efficient way to earn a Bachelor of Science in Nursing, preparing students for various advanced immunology-related positions in healthcare. Combining immunology studies with these nursing pathways creates a robust platform for a fulfilling career.

Best Scientists Citing Javier Martinez-Picado

Trending Scientists